Melatonin and depression : a translational perspective from animal models to clinical studies

Detalhes bibliográficos
Autor(a) principal: Tonon, André Comiran
Data de Publicação: 2021
Outros Autores: Pilz, Luísa Klaus, Markus, Regina Pekelmann, Hidalgo, Maria Paz Loayza, Elisabetsky, Elaine
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/240285
Resumo: Daily rhythm of melatonin synchronizes the body to the light/dark environmental cycle. Several hypotheses have been raised to understand the intersections between melatonin and depression, in which changes in rest-activity and sleep patterns are prominent. This review describes key experimental and clinical evidence that link melatonin with the etiopathology and symptomatology of depressive states, its role in the follow up of therapeutic response to antidepressants, as well as the clinical evidence of melatonin as MDD treatment. Melatonin, as an internal temporal cue contributing to circadian organization and best studied in the context of circadian misalignment, is also implicated in neuroplasticity. The monoaminergic systems that underly MDD and melatonin production overlap. In addition, the urinary metabolite 6-sulfatoxymelatonin (aMT6) has been proposed as biomarker for antidepressant responders, by revealing whether the blockage of noradrenaline uptake has taken place within 24 h from the first antidepressant dose. Even though animal models show benefits from melatonin supplementation on depressive-like behavior, clinical evidence is inconsistent vis-à-vis prophylactic or therapeutic benefits of melatonin or melatonin agonists in depression. We argue that the study of melatonin in MDD or other psychiatric disorders must take into account the specificities of melatonin as an integrating molecule, inextricably linked to entrainment, metabolism, immunity, neurotransmission, and cell homeostasis.
id UFRGS-2_f5b6adeda2f195fb860f29837fcc5ed3
oai_identifier_str oai:www.lume.ufrgs.br:10183/240285
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Tonon, André ComiranPilz, Luísa KlausMarkus, Regina PekelmannHidalgo, Maria Paz LoayzaElisabetsky, Elaine2022-06-15T04:42:31Z20211664-0640http://hdl.handle.net/10183/240285001139782Daily rhythm of melatonin synchronizes the body to the light/dark environmental cycle. Several hypotheses have been raised to understand the intersections between melatonin and depression, in which changes in rest-activity and sleep patterns are prominent. This review describes key experimental and clinical evidence that link melatonin with the etiopathology and symptomatology of depressive states, its role in the follow up of therapeutic response to antidepressants, as well as the clinical evidence of melatonin as MDD treatment. Melatonin, as an internal temporal cue contributing to circadian organization and best studied in the context of circadian misalignment, is also implicated in neuroplasticity. The monoaminergic systems that underly MDD and melatonin production overlap. In addition, the urinary metabolite 6-sulfatoxymelatonin (aMT6) has been proposed as biomarker for antidepressant responders, by revealing whether the blockage of noradrenaline uptake has taken place within 24 h from the first antidepressant dose. Even though animal models show benefits from melatonin supplementation on depressive-like behavior, clinical evidence is inconsistent vis-à-vis prophylactic or therapeutic benefits of melatonin or melatonin agonists in depression. We argue that the study of melatonin in MDD or other psychiatric disorders must take into account the specificities of melatonin as an integrating molecule, inextricably linked to entrainment, metabolism, immunity, neurotransmission, and cell homeostasis.application/pdfengFrontiers in psychiatry. Lausanne. Vol. 12 (2021), 638981, 13 p.BiomarcadoresTranstornos do humorRitmo circadianoCronobiologiaDepressãoMelatoninaModelos animaisEstudo clínicoPsychiatryMood disorderNeuropsychaitric disordersBehaviorBiological rhythmsChronobiology6-sulfatoxymelatonin (aMT6s)BiomarkerMelatonin and depression : a translational perspective from animal models to clinical studiesEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001139782.pdf.txt001139782.pdf.txtExtracted Texttext/plain78938http://www.lume.ufrgs.br/bitstream/10183/240285/2/001139782.pdf.txt77276d8368266b3ba2dac92af98723b3MD52ORIGINAL001139782.pdfTexto completo (inglês)application/pdf873281http://www.lume.ufrgs.br/bitstream/10183/240285/1/001139782.pdfb286a61ec21a35404800d19a14df33c2MD5110183/2402852022-06-16 04:41:31.055454oai:www.lume.ufrgs.br:10183/240285Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2022-06-16T07:41:31Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Melatonin and depression : a translational perspective from animal models to clinical studies
title Melatonin and depression : a translational perspective from animal models to clinical studies
spellingShingle Melatonin and depression : a translational perspective from animal models to clinical studies
Tonon, André Comiran
Biomarcadores
Transtornos do humor
Ritmo circadiano
Cronobiologia
Depressão
Melatonina
Modelos animais
Estudo clínico
Psychiatry
Mood disorder
Neuropsychaitric disorders
Behavior
Biological rhythms
Chronobiology
6-sulfatoxymelatonin (aMT6s)
Biomarker
title_short Melatonin and depression : a translational perspective from animal models to clinical studies
title_full Melatonin and depression : a translational perspective from animal models to clinical studies
title_fullStr Melatonin and depression : a translational perspective from animal models to clinical studies
title_full_unstemmed Melatonin and depression : a translational perspective from animal models to clinical studies
title_sort Melatonin and depression : a translational perspective from animal models to clinical studies
author Tonon, André Comiran
author_facet Tonon, André Comiran
Pilz, Luísa Klaus
Markus, Regina Pekelmann
Hidalgo, Maria Paz Loayza
Elisabetsky, Elaine
author_role author
author2 Pilz, Luísa Klaus
Markus, Regina Pekelmann
Hidalgo, Maria Paz Loayza
Elisabetsky, Elaine
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Tonon, André Comiran
Pilz, Luísa Klaus
Markus, Regina Pekelmann
Hidalgo, Maria Paz Loayza
Elisabetsky, Elaine
dc.subject.por.fl_str_mv Biomarcadores
Transtornos do humor
Ritmo circadiano
Cronobiologia
Depressão
Melatonina
Modelos animais
Estudo clínico
topic Biomarcadores
Transtornos do humor
Ritmo circadiano
Cronobiologia
Depressão
Melatonina
Modelos animais
Estudo clínico
Psychiatry
Mood disorder
Neuropsychaitric disorders
Behavior
Biological rhythms
Chronobiology
6-sulfatoxymelatonin (aMT6s)
Biomarker
dc.subject.eng.fl_str_mv Psychiatry
Mood disorder
Neuropsychaitric disorders
Behavior
Biological rhythms
Chronobiology
6-sulfatoxymelatonin (aMT6s)
Biomarker
description Daily rhythm of melatonin synchronizes the body to the light/dark environmental cycle. Several hypotheses have been raised to understand the intersections between melatonin and depression, in which changes in rest-activity and sleep patterns are prominent. This review describes key experimental and clinical evidence that link melatonin with the etiopathology and symptomatology of depressive states, its role in the follow up of therapeutic response to antidepressants, as well as the clinical evidence of melatonin as MDD treatment. Melatonin, as an internal temporal cue contributing to circadian organization and best studied in the context of circadian misalignment, is also implicated in neuroplasticity. The monoaminergic systems that underly MDD and melatonin production overlap. In addition, the urinary metabolite 6-sulfatoxymelatonin (aMT6) has been proposed as biomarker for antidepressant responders, by revealing whether the blockage of noradrenaline uptake has taken place within 24 h from the first antidepressant dose. Even though animal models show benefits from melatonin supplementation on depressive-like behavior, clinical evidence is inconsistent vis-à-vis prophylactic or therapeutic benefits of melatonin or melatonin agonists in depression. We argue that the study of melatonin in MDD or other psychiatric disorders must take into account the specificities of melatonin as an integrating molecule, inextricably linked to entrainment, metabolism, immunity, neurotransmission, and cell homeostasis.
publishDate 2021
dc.date.issued.fl_str_mv 2021
dc.date.accessioned.fl_str_mv 2022-06-15T04:42:31Z
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/240285
dc.identifier.issn.pt_BR.fl_str_mv 1664-0640
dc.identifier.nrb.pt_BR.fl_str_mv 001139782
identifier_str_mv 1664-0640
001139782
url http://hdl.handle.net/10183/240285
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Frontiers in psychiatry. Lausanne. Vol. 12 (2021), 638981, 13 p.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/240285/2/001139782.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/240285/1/001139782.pdf
bitstream.checksum.fl_str_mv 77276d8368266b3ba2dac92af98723b3
b286a61ec21a35404800d19a14df33c2
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1815447795185745920